Glucotrack (GCTK) Return on Capital Employed (2011 - 2025)
Glucotrack (GCTK) recorded quarterly Return on Capital Employed of 488.91% in Q4 2025, down 17.44% on a QoQ basis from 416.32% in Q3 2025, and up 20249.0% year-over-year from N/an in Q4 2024.
Glucotrack (GCTK) Return on Capital Employed (2011 - 2025) Analysis & Trends
Glucotrack has disclosed Return on Capital Employed across 14 years of filings, most recently posting 488.91% for Q4 2025.
- Quarterly Return on Capital Employed rose 20249.0% year-over-year to 488.91% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 488.91% (up 20249.0% YoY) and the FY2025 annual result came in at 761.84%, down 41076.0% from the prior year.
- Return on Capital Employed slipped to 488.91% in Q4 2025, from 416.32% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 524.66% in Q2 2024 and troughed at 691.4% in Q4 2024.
- A 5-year average of 168.74% and a median of 135.8% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed surged 63973 bps — and 2025, when it tumbled 75299 bps.
- Tracing GCTK's Return on Capital Employed over 5 years: stood at 66.6% in 2021, then slumped by 239 bps to 225.95% in 2022, then jumped by 31 bps to 156.54% in 2023, then plunged by 342 bps to 691.4% in 2024, then rose by 29 bps to 488.91% in 2025.
- Business Quant data shows GCTK's Return on Capital Employed at 488.91% in Q4 2025, 416.32% in Q3 2025, and 225.59% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 17.54% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 5.02% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 25.95% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 18.63% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 19.44% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 4.68% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 12.74% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 13.02% |
| 10 | Glucotrack | 4.26 | -7.38 Mn | - | -488.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -488.91% |
| Sep 30, 2025 | -416.32% |
| Jun 30, 2025 | -225.59% |
| Mar 31, 2025 | -259.26% |
| Dec 31, 2024 | -691.40% |
| Sep 30, 2024 | 336.67% |
| Jun 30, 2024 | 524.66% |
| Mar 31, 2024 | -433.46% |
| Dec 31, 2023 | -156.54% |
| Sep 30, 2023 | -90.04% |
| Jun 30, 2023 | -115.06% |
| Mar 31, 2023 | -579.69% |
| Dec 31, 2022 | -225.95% |
| Sep 30, 2022 | -157.65% |
| Jun 30, 2022 | -114.96% |
| Mar 31, 2022 | -86.54% |
| Dec 31, 2021 | -66.60% |
| Sep 30, 2021 | -47.27% |
| Jun 30, 2021 | -44.00% |
| Mar 31, 2021 | -36.89% |